ANN ARBOR, Mich., March 28, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that company president and CEO Tim Mayleben will present at the Needham & Company 11th Annual Healthcare Conference for institutional investors and venture capital firms. The conference will be held April 3-4, 2012 at the New York Palace Hotel in New York City.
